Terry M. Jones

University of Liverpool — United Kingdom

Medicine · Health Sciences

32h-index4.1kcitations135works3.22yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Head and Neck Cancer Studies(40), Acne and Rosacea Treatments and Effects(22), Tracheal and airway disorders(14), Salivary Gland Tumors Diagnosis and Treatment(11), Head and Neck Surgical Oncology(10)

Publications135 total

Frequent HPV-independent p16/INK4A overexpression in head and neck cancer
UNC Libraries·2025Open Access
The effect of PuraBond® on postoperative pain following transoral resections of primary oral or oropharyngeal neoplastic mucosal lesions: A blinded randomised controlled study (PuraBond® PROOF)
European Journal of Surgical Oncology·2025Open Access
Efficacy, Safety, and Tolerability of Oral DFD-29, a Low-Dose Formulation of Minocycline, in Rosacea
JAMA Dermatology·2025· 4 cited
Reflection on Transoral Robotic Surgery vs Transoral Laser Microsurgery in HPV-Positive Oropharyngeal Squamous Cell Carcinoma—Reply
JAMA Otolaryngology–Head & Neck Surgery·2025
Stell & Maran's Head and Neck Surgery and Oncology
2024
Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma
JAMA Otolaryngology–Head & Neck Surgery·2024· 12 citedOpen Access
49 Development of a Normal Tissue Complication Probability Model for Dysphagia in PATHOS trial patients
Radiotherapy and Oncology·2024Open Access
Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm<sup>2</sup>: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis
Clinical Pharmacology in Drug Development·2024· 13 citedOpen Access
Transoral Resection for Oropharyngeal Neoplasms
Springer surgery atlas series·2024
Abstract PO-036: A deep learning alternative to regional molecular testing for HPV status
Clinical Cancer Research·2023· 1 cited
43735 Safety and Tolerability of a single 5-day Treatment Cycle of Tirbanibulin Ointment 1% in Large Field (100cm2): A phase I Trial in patients with Actinic Keratosis
Journal of the American Academy of Dermatology·2023Open Access
Supplemental Tables 1 through 3 from HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
2023Open Access
Data from HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
2023Open Access
Supplemental Tables 1 through 3 from HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
2023Open Access
Data from HPV-Related Oropharynx Cancer in the United Kingdom: An Evolution in the Understanding of Disease Etiology
2023Open Access
Supplementary Figure Legend from Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling
2023Open Access
Supplementary Methods and References from Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling
2023Open Access
Supplementary Figures S1-S6 from Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling
2023Open Access
Data from Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling
2023Open Access
Supplementary Tables S1-S8 from Dsh Homolog DVL3 Mediates Resistance to IGFIR Inhibition by Regulating IGF-RAS Signaling
2023Open Access
page 1 of 7Next →

Frequent Co-authors

Andrew Schache(8), Richard Shaw(8), Eduardo Tschen(6), Max Robinson(5), Mererid Evans(5), Michael Jarratt(5), Jeffrey Lancaster(5), Hisham Mehanna(4), Anne W. Lucky(4), Steven Kempers(4), John A. McLane(4), Nicholas J. Roland(4), Ned Powell(3), Navdeep Upile(3), Gareth J. Thomas(3), Emma V. King(3), Dennis J. McCance(3), Jacqueline A. James(3), Michael Moran(3), Lawrence F. Eichenfield(3)